Our commitment to quality: batch by batch

Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.

Podcasts

Neil Smith featured on Planted with Sara Payan.

Sara discusses the European cannabis landscape and new movement in R&D with Neil Smith, COO of German bio-pharmaceutical company Avextra.

Press Releases

Please find the latest press releases from Avextra here.

Avextra und SynQube GmbH geben strategische Partnerschaft in der Arzneimittelentwicklung bekannt

Avextra und SynQube GmbH geben strategische Partnerschaft in der Arzneimittelentwicklung bekannt

Avextra und SynQube geben ihre strategische Partnerschaft bekannt. Beide Partner bündeln ihre umfangreiche Expertise im Bereich der Cannabistherapie für eine verbesserte Patientenversorgung in der GKV-Erstattung.

Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors

Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors

BENSHEIM, Germany, Feb. 07, 2024 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines…

Mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Bensheim, 23.01.2024 – Erste Studien zeigen, dass neuropathische Schmerzformen, wie CINP, eine vielversprechende Indikation für den Nutzen von CBMs darstellen könnten. Jedoch fehlt – wie…

Avextras stellt seine Allianz für evidenzbasierte Cannabis-Medizin vor und kündigt seine Unterstützung für BELCANTO an.

Avextras stellt seine Allianz für evidenzbasierte Cannabis-Medizin vor und kündigt seine Unterstützung für BELCANTO an.

Bensheim, 18.10.2023 – Zum Deutschen Schmerzkongress in Mannheim kündigt Avextra seine Allianz für Evidenz mit dem Start von BELCANTO an: der ersten von Avextra unterstützten…

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra und die Deutsche Gesellschaft für Schmerzmedizin – mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Avextra und die Deutsche Gesellschaft für Schmerzmedizin – mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Deutschland legt Plan zur begrenzten Legalisierung von Cannabis für den Freizeitgebrauch in abgestufter Form vor.

Deutschland legt Plan zur begrenzten Legalisierung von Cannabis für den Freizeitgebrauch in abgestufter Form vor.

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development

Avextra and SynQube jointly announce their strategic partnership. Both partners are combining their extensive expertise in the field of cannabinoid therapy to improve patient care…

Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors

Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors

BENSHEIM, Germany, Feb. 07, 2024 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines…

German Pain Association (DGS) and pharmaceutical company Avextra join forces to launch their new study OCEAN

German Pain Association (DGS) and pharmaceutical company Avextra join forces to launch their new study OCEAN

Bensheim, Germany, January 23, 2024 – Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines (CBMs) located…

AVEXTRA invests up to 15 million euros in the development of new medical cannabis research in partnership with IUCS-CESPU

AVEXTRA invests up to 15 million euros in the development of new medical cannabis research in partnership with IUCS-CESPU

Lisbon, January 17th, 2024 – Avextra, the leading German manufacturer of cannabis-based medicines, has entered a strategic, long-term partnership with the Instituto Universitário de Ciências…

Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients

Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients

Bensheim, 18.10.2023 – Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world…

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Germany unveils scaled-down recreational cannabis legalization plan

Germany unveils scaled-down recreational cannabis legalization plan

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

PRESS CONTaCT

Lisa Schwede

Tel.: +49 30 408174037

E-Mail: press@avextra.com

EN